Vaxcyte, Inc. - Common Stock (PCVX)
89.34
+2.83 (3.27%)
Vaxcyte Inc is a biotechnology company focused on developing innovative vaccines to address significant infectious diseases
The company's research and development efforts center on utilizing its proprietary technology platform to design and produce a new generation of polysaccharide-based vaccines. By targeting a range of pathogens, Vaxcyte aims to enhance immune response and provide effective prevention measures against diseases that disproportionately affect public health. Through its work, the company seeks to contribute to a healthier global population by advancing the science of vaccinology.
Frequently Asked Questions
Is Vaxcyte, Inc. - Common Stock publicly traded?
Yes, Vaxcyte, Inc. - Common Stock is publicly traded.
What exchange does Vaxcyte, Inc. - Common Stock trade on?
Vaxcyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vaxcyte, Inc. - Common Stock?
The ticker symbol for Vaxcyte, Inc. - Common Stock is PCVX on the Nasdaq Stock Market
What is the current price of Vaxcyte, Inc. - Common Stock?
The current price of Vaxcyte, Inc. - Common Stock is 89.34
When was Vaxcyte, Inc. - Common Stock last traded?
The last trade of Vaxcyte, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Vaxcyte, Inc. - Common Stock?
The market capitalization of Vaxcyte, Inc. - Common Stock is 8.37B
How many shares of Vaxcyte, Inc. - Common Stock are outstanding?
Vaxcyte, Inc. - Common Stock has 93.71M shares outstanding.